Valuation: Devyser Diagnostics AB

Market Cap 994M 103M 90.14M 83.03M 77.07M 146M 9.82B 148M 387M 4.82B 387M 378M 16.71B P/E 2026 *
23.7x
P/E 2027 * 12.7x
Enterprise Value 930M 96.29M 84.33M 77.68M 72.1M 137M 9.19B 139M 362M 4.51B 362M 354M 15.63B EV / Sales 2026 *
3.09x
EV / Sales 2027 * 2.53x
Free-Float
71.17%
Yield 2026 *
-
Yield 2027 * -
1 day-2.47%
1 week-31.08%
Current month-31.00%
1 month-35.79%
3 months-23.42%
6 months-46.47%
Current year-48.16%
1 week 57.8
Extreme 57.8
85.6
1 month 57.8
Extreme 57.8
94.6
Current year 57.8
Extreme 57.8
114.8
1 year 57.8
Extreme 57.8
159.6
3 years 57.4
Extreme 57.4
159.6
5 years 56.1
Extreme 56.1
159.6
10 years 56.1
Extreme 56.1
159.6
Manager TitleAgeSince
Chief Executive Officer 59 2025-08-03
Director of Finance/CFO 43 2020-12-31
Chief Tech/Sci/R&D Officer 48 2024-01-31
Director TitleAgeSince
Director/Board Member 72 2020-12-31
Director/Board Member 59 2023-12-31
Director/Board Member 48 2024-12-31
Date Insider Type Main position Quantity % Market Cap.
06-09Others

Director

10,000 0.0600%
06-09Others

Director

76,251 0.4579%
06-01Others

Director

76,251 0.4579%
Change 5-day change 1-year change 3-year change Capi.($)
-2.47%-31.08%-54.46%-23.12% 106M
+1.08%+7.56%+3.61%+9.84% 49.92B
+0.40%-1.37%+401.69%+625.15% 40.23B
-0.52%+6.57%+25.41%-5.37% 34.55B
+3.97%+6.71%+26.06%+63.36% 33.09B
-4.19%-1.84%+3.76%+32.17% 27.51B
-2.40%+1.60% - - 17.05B
+1.34%+5.68%+75.77%+141.51% 15.92B
-0.95%+0.76%+12.92%+21.59% 13.86B
+1.69%+3.09%+93.44%+99.19% 13.52B
Average -0.21%+0.96%+65.35%+107.15% 24.58B
Weighted average by Cap. +0.24%+4.48%+91.06%+141.35%

Financials

2026 *2027 *
Net sales 301M 31.15M 27.29M 25.13M 23.33M 44.3M 2.97B 44.9M 117M 1.46B 117M 114M 5.06B 372M 38.56M 33.77M 31.11M 28.87M 54.83M 3.68B 55.57M 145M 1.81B 145M 142M 6.26B
Net income 40.91M 4.24M 3.71M 3.42M 3.17M 6.02M 404M 6.11M 15.92M 198M 15.91M 15.56M 688M 76.5M 7.92M 6.94M 6.39M 5.93M 11.26M 756M 11.42M 29.77M 371M 29.75M 29.1M 1.29B
Net Debt -64.07M -6.64M -5.81M -5.35M -4.97M -9.43M -633M -9.56M -24.93M -311M -24.92M -24.37M -1.08B -52.81M -5.47M -4.79M -4.41M -4.09M -7.78M -522M -7.88M -20.55M -256M -20.54M -20.09M -888M
Logo Devyser Diagnostics AB
Devyser Diagnostics AB is a Sweden-based company engaged in development, manufacture ad sale of kits for genetic testing in routing diagnostic to laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The company has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The Company provides its products in more than 45 countries.
Employees
110
Date Price Change Volume
26-07-06 SEK 59.20 -2.47% 137,839
26-07-03 SEK 60.70 -26.78% 585,731
26-07-02 SEK 82.90 -0.72% 14,285
26-07-01 SEK 83.50 -2.68% 5,548
26-06-30 SEK 85.80 -0.12% 26,325
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
40.14DKK
Average target price
104.59DKK
Spread / Average Target
+160.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DVYSR Stock